• Another EU patent for Verona in COPD drug pharmatimes
    April 10, 2019
    The European Patent Office has granted Verona pharma an additional key patent for its chronic obstructive pulmonary disease (COPD) drug, ensifentrine (RPL554)...
PharmaSources Customer Service